ScanSource (SCSC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Fiscal 2025 saw strong free cash flow and gross profit growth, with net sales of just over $3 billion, a 6.7% decline year-over-year, but gross profit and adjusted EBITDA grew by 2.4% and 2.8%, respectively, with improved margins and a 15.9% increase in non-GAAP EPS.
Recurring revenues rose to 32.8% of consolidated gross profits, and share repurchases totaled $106.5 million; the company ended the year with $126 million in cash and an adjusted ROIC of 13.6%.
Acquisitions of Resourcive and Advantix in August 2024 were accretive, and the company maintains an active M&A pipeline, with disciplined capital allocation and a targeted net debt leverage of 1–2x adjusted EBITDA.
Mid-term (3-year) goals include 5–7% gross profit CAGR, recurring revenue at 50% of gross profit, ~6% adjusted EBITDA margin, 80%+ free cash flow conversion, and mid-teens ROIC.
The company is focused on delivering converged IT, connectivity, and cloud solutions, positioning itself as a leader in a rapidly evolving technology distribution ecosystem.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of eight director nominees, (2) advisory approval of named executive officer compensation, and (3) ratification of Deloitte & Touche LLP as the independent auditor for FY2026.
Each share of common stock is entitled to one vote; no cumulative voting is allowed.
Shareholder proposals for the 2026 annual meeting must be received by June 25, 2026, and comply with SEC rules and company bylaws.
Board of directors and corporate governance
The board consists of eight members, with a majority being independent; the CEO also serves as Chair, with a Lead Independent Director providing additional oversight.
Board committees (Audit, Compensation, Nominating and Corporate Governance) are composed entirely of independent directors.
Directors are elected annually by majority vote in uncontested elections, and the board conducts annual self-evaluations and succession planning.
Anti-pledging and anti-hedging policies are in place for directors and officers.
Shareholder engagement is a key focus, with outreach to over 60% of shares outstanding in the past year.
Latest events from ScanSource
- Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference5 Mar 2026 - Q2 FY26 sales grew 2.5%, but margin pressure led to reduced full-year guidance.SCSC
Q2 20265 Feb 2026 - Sales fell but margins, cash flow, and acquisitions support growth amid market uncertainty.SCSC
Q4 202423 Jan 2026 - Recurring revenue and margin gains offset sales decline; FY25 outlook reaffirmed.SCSC
Q1 202515 Jan 2026 - Hybrid distribution and recurring revenue drive growth, with a focus on cash flow and strategic M&A.SCSC
Raymond James 2024 TMT & Consumer Conference11 Jan 2026 - Sales fell 15.5% but margin and recurring revenue rose; FY25 guidance reaffirmed.SCSC
Q2 20259 Jan 2026 - Recurring revenue now exceeds 30% of gross profit, fueling margin expansion and strategic growth.SCSC
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202514 Dec 2025 - Transformation to a converged hardware and recurring revenue model drives growth and margin expansion.SCSC
Raymond James TMT and Consumer Conference10 Dec 2025 - Shareholders to vote on directors, executive pay, auditor, and new incentive plan amid strong cash flow.SCSC
Proxy Filing1 Dec 2025